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1. Introduction  
Anterior cruciate ligament (ACL) injury is a relatively common knee injury during sports 
activities (Uhorchak, 2003). A torn ACL usually occurs through a twisting force being 
applied to the knee whilst the foot is firmly planted on the ground or upon landing (Boden, 
2000). The traditional surgical treatment for ACL rupture is ACL reconstruction by an 
autogenous tendon graft. However, fibroblasts of the tendon graft are necrotized 
immediately after transplantation of an autogenous tendon graft, and, then, extrinsic 
fibroblasts infiltrate in the graft (Amiel, 1986; Arnoczky, 1982; Kleiner 1986). During this 
process, the grafted tendon weakens in the early phase after ACL reconstruction surgery, 
even if the grafted tendon is subjected in the mechanically physiological condition (Jackson 
1991). In addition, a case report of histology of patellar tendon graft 18 months after ACL 
reconstruction suggested that the cell infiltration into a core portion of the graft occurs very 
slowly after ligament reconstruction (Delay, 2002). The slow graft maturation may result in 
graft failure during the postoperative rehabilitation period. It has been known that growth 
factors enhance proliferation, migration, and matrix synthesis of cells in vitro (Deie, 1997; 
DesRosiers, 1996; Kobayashi, 2000; Marui, 1997; Scherping, 1997; Schmidt, 1995). The 
authors conducted a series of animal experimental studies for the application of growth 
factors to ligament reconstruction. We will review our recent experimental studies that 
intended to enhance mechanical strength of grafted tendon after ligament reconstruction 
using growth factors.  
2. Biological characteristics of infiltrative fibroblasts into the necrotized 
tendon 
Previous studies have demonstrated that, in the grafted tendon for ligament reconstruction, 
fibroblast repopulation from an extrinsic origin occurs with revascularization after intrinsic 
fibroblasts in the tendon are necrotized (Kleiner 1986). The authors have reported that 
infiltration of the extrinsic fibroblasts results in mechanical deterioration of the extracellular 
matrix of the grafted tendon (Tohyama 2000, Tohyama 2006). Thus, the infiltrative 
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fibroblasts play an important role in remodeling of the autogenous tendon graft. Infiltrative 
fibroblasts repopulating in the skin wound are phenotypically distinct from normal dermal 
fibroblasts. Amiel et al. (1995) and Hannafin et al. (1999) reported that proliferation and 
migration characteristics of the ligament fibroblasts depended on their origin. Therefore, 
there is a high possibility that extrinsic fibroblasts infiltrating in the necrotized tendon have 
significantly different biological characteristics, compared with the intrinsic fibroblasts in 
the normal tendon. To understand the remodeling of the tendon autograft in ligament 
reconstruction, it is necessary to clarify differences in biological characteristics between the 
infiltrative and intrinsic fibroblasts.  
We have compared the biological characteristics of infiltrative fibroblasts into the patellar 
tendon after fibroblast necrosis using an in situ freeze-thaw procedure to normal patellar 
tendon fibroblasts (Ikema, 2005; Tohyama, 2007). The in situ frozen-thawed patellar tendon 
simulates ligament reconstruction with the patellar tendon graft under ideal condition. To 
obtain the infiltrative fibroblasts, we performed an in situ freeze-thaw treatment on the 
patellar tendon to kill the intrinsic fibroblasts (Fig. 1). In this in situ freeze-thaw treatment, 
the patellar tendon was frozen with liquid nitrogen for 1 minute. The frozen patellar tendon 
was then thawed by physiological saline solution. We confirmed that this procedure killed 
97% to 100% of intrinsic fibroblasts in the rabbit patellar tendon. After this treatment, only 
the extrinsic fibroblasts were available to repopulate in the patellar tendon (Tohyama, 2000). 
Six weeks later, the patellar tendons were harvested and placed in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% FBS. A confluent monolayer formed in 2 weeks. 
Thus, infiltrative cells, >95% fibroblast-like as confirmed by microscopic analysis, were 
obtained from the right patellar tendon. For comparison, the untreated patellar tendon was 
similarly incubated and normal fibroblasts were isolated in the same manner.  
 
 
Fig. 1. The in situ freeze-thaw treatment for necrotizing intrinsic fibroblasts in the patellar 
tendon (From ref. Ikema (2005)) 
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Fig. 2. Cellular proliferation (a), migration (b) and responsiveness to IL-1beta  
(c) of infiltrative fibroblasts (IFs) and normal fibroblasts (NFs) (From ref. Ikema (2005) and 
ref. Tohyama (2007)). 
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The authors then found that the cellular proliferation, migration, and responsiveness of 
infiltrative fibroblasts to IL-1beta, which is one of the major inflammatory cytocine, are quite 
inferior to those of normal fibroblasts (Fig. 2)(Ikema, 2005; Tohyama, 2007). The slow 
remodeling process in the tendon graft may be attributed to these inferior potentials of 
infiltrative fibroblasts. Therefore, we may be able to accelerate the remodeling process of the 
grafted tendon after ligament reconstruction if we restore the potentials of infiltrative 
fibroblasts to the levels of normal tendon fibroblasts with regard to cellular proliferation, 
migration, and responsiveness to cytokines. 
3. Growth factor application to the graft after ACL reconstruction 
As described above, previous studies have demonstrated that intrinsic fibroblasts in the 
tendon grafted across the knee joint to reconstruct the ACL are necrotized immediately after 
transplantation, and that cellular repopulation from an extrinsic origin and 
revascularization sequentially occur (Arnoczky, 1982; Kleiner, 1986). In this process, the 
mechanical properties of tendon autografts deteriorated after ligament reconstruction 
surgery, and they remain inferior even at 8 months after surgery (Beynnon, 1997). Also, the 
cell infiltration into the grafted tendon occurs very slowly after ACL reconstruction (Delay, 
2002). Recently, a number of studies have shown that application of various growth factors 
stimulates cellular proliferation, angiogenesis, and synthesis of extra-cellular matrix in 
tendon and ligament tissues (Deie, 1997; DesRosiers, 1996; Kobayashi, 2000; Marui, 1997; 
Scherping, 1997; Schmidt, 1995; Zachary, 1998). Therefore, there are two approaches in the 
application of growth factor to the graft after ACL reconstruction. The first approach is to 
enhance angiogenesis and cellular repopulation in the grafted tendon after the necrosis. The 
second one is to improve tissue quality of the grafted tendon via remodelling of the collagen 
matrix after ACL reconstruction.     
3.1 Growth factor application for enhancement of angiogenesis  
Angiogenesis is a biological mechanism of new capillary formation and involves the 
activation, migration, and proliferation of endothelial cells from preexisting venules. 
Angiogenesis can be influenced by many factors including hypoxia, growth factors, and 
matrix components.  The angiogenic activation of endothelial cells probably plays a role in 
promoting and regulating other biological events, such as inflammation, fibroblast 
proliferation, and extracellular matrix synthesis in the remodeling process of the grafted 
tendon after ACL reconstruction.  Vascular endothelial growth factor (VEGF) is considered 
to be a potent mediator of angiogenesis in various pathological conditions (Ferrara and 
Davis-Smyth, 1997). Recently, our study in the rabbit ACL reconstruction model clarified 
that infiltrative cells produced VEGF before revascularization in the grafted tendon (Fig. 3) 
(Yoshikawa, 2006a). This has suggested that VEGF mediates angiogenesis in the intra-
articular tendon graft for the ACL reconstruction.   
Based on our finding, an administration of VEGF may significantly enhance angiogenesis in 
the grafted tendon after ACL reconstruction and then may accelerate the remodeling 
process of the grafted tendon after necrosis.  On the other hand, there is also a possibility 
that the revascularization induced by VEGF deteriorates the mechanical strength of the 
grafted tendon. Newly formed vessels in the graft may weaken the grafted tendon as soft-
tissue “flaws” (Shrive, 1995). Therefore, we examined the effect of an application of VEGF in  
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Fig. 3. Immunohistologies for proliferative cells (PCNA stain)(A: 2 weeks, B: 8 weeks), VEGF 
(C: 2 weeks, D: 8 weeks), and vascular endothelial cells (CD31 stain) (E: 3 weeks, F: 8 weeks) 
of the patellar tendon graft after ACL reconstruction in the rabbit model.  A: Proliferative 
cells were frequently found at the superficial portion of the tendon graft at 2 weeks. B: At 8 
weeks, few proliferative cells were observed in the patellar tendon graft.  C: At 2 weeks, 
VEGF-positive cells scattered at the similar area where proliferative cells existed.  D: At 8 
weeks, VEGF-positive cells were seldom observed in the patellar tendon graft.  E: At 3 
weeks, vascular endothelial cells appeared at the midsubstance portion apart from the 
surface area of the graft tendon in spite of lack of vessel formation at this time.  F: At 8 
weeks, a number of vessel formations were observed in the tendon graft (From ref. 
Yoshikawa (2006a)). 
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the rabbit in situ frozen-thawed ACL and the sheep ACL reconstruction models. The in situ 
frozen-thawed ACL, which is anatomical but acellular, has been established as an idealized 
ACL graft model (Jackson, 1991; Katsuragi, 2000; Sakai, 2002). In the rabbit model, we 
performed the freeze–thaw treatment for the right ACL (Fig.４) and then injected 30-µg 
VEGF with 0.2-ml phosphate-buffered saline in the right knee joint. Several vessels formed 
by endothelial cells were observed at the superficial portion of the ACL 3 weeks after the in 
situ freeze-thaw treatment and VEGF injection, while few vascular endothelial cells were 
found in the ACL at 3 weeks after the in situ freeze-thaw treatment alone (Fig. 5)(Ju, 2006).  
The number of vessels with endothelial cells was significantly higher in the ACLs after the 
in situ freeze-thaw treatment and VEGF injection than in the ACLs after the in situ freeze-
thaw treatment alone (Fig. 5). This finding implied that recombinant VEGF therapy may be 
used to enhance graft remodeling in ACL reconstruction.  However, the in situ frozen–
thawed ACL was not a true model of ACL reconstruction by use of a free tendon graft.  
Biological differences must exist between the frozen-thawed ACL and the intra-articular 
grafted tendon after ACL reconstruction, since bone marrow-derived cells contribute to a 
graft that is placed in a bone tunnel.  Therefore, we conducted a following large animal 
model study to clarify if recombinant VEGF application affects the mechanical properties of 
the grafted tendon after ACL reconstruction before its clinical application of recombinant 
VEGF therapy to ACL reconstruction. 
In this experiment, we used mature female Suffolk sheep (Yoshikawa, 2006b) . We harvested 
the semitendinosus tendon from the right leg and then soaked the tendon in recombinant 
human VEGF with 10-ml phosphate buffered saline (PBS) for 15 minutes and then perfrmed 
ACL reconstruction using this semitendinosus tendon in the same leg (Fig. 6). These animals 
were killed 12 weeks after ACL reconstruction for the histological and biomechanical 
evaluations. Conserning mechanical evaluation, the antero-posterior (A-P) drawer tests 
were performed in 30°, 60°, and 90° of flexion and neutral rotation with load application. 
The knee was mounted to a custom-made adjusting device with 3 degrees of freedom 
(translations in the anterior-posterior, medial-lateral, and proximal-distal directions) in a 
materials testing machine. An A-P force of ±100 N was applied 15 times with a load 
displacement rate of 50 mm/min and the A-P displacement between ±100-N A-P forces was 
quantified. After A-P drawer testing, all soft tissue including the menisci was removed, 
leaving only the grafted tendon. The cross-sectional area of the graft was measured at the 
middle level of intra-articular portion of the graft by a non-contact optical method with 
video dimension analyzer. The femur-graft-tibia (FGT) complex underwent tensile testing at 
the cross head speed of 50 mm/min until the FGT complex failed. 
The A-P translation of the tibia relative to the femur in the experimental group was 
significantly larger than that in the control group, in which the knee underwent identical 
procedures to those of the experimental group except that the harvested tendon was 
soaked in 10-ml PBS instead of recombinant VEGF with 10-ml PBS (Fig. 7) (Yoshikawa, 
2006). At the failure tests to determine the structural properties of the femur-graft-tibia 
complex, all grafts failed at the midsubstance portion in the graft during tensile testing, 
while normal ACL specimens had avulsion fractures at the tibial insertion sites to the 
ACLs. The linear stiffness of the femur-graft-tibia complex in the experimental group was 
significantly lower than that in the control group, while there were no significant 
differences in the ultimate failure load or the energy absorbed at failure between the 
experimental and the control group (Fig. 8). 
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Fig. 4. Immunohistologies for vascular endothelial cells to evaluate the effects of local 
VEGF application on vessel formation in the ACL at 3 weeks (A,B,C), 6 weeks (D,E,F), and 
12 weeks (G,H,I) after the in situ freeze-thaw treatment in the rabbit model (CD31 stain). 
At 3, 6, and 12 weeks after surgery, we did not find any obvious differences in 
angiogenesis between the ACLs with (C,F, and I) and without intra-articular injection 
of.2-ml phosphate-buffered saline (A, D, G). On the other hand, several vessels formed by 
endothelial cells were observed at the superficial portion of the ACL 3 weeks after the in 
situ freeze-thaw treatment and VEGF injection (B) (Ju, 2006). The number of vessels with 
endothelial cells was significantly higher in the ACLs after the in situ freeze-thaw 
treatment and VEGF injection (B,E,H) than in the ACLs after the in situ freeze-thaw 
treatment alone (B,E,H)(Fig. 5).(From ref. Ju (2006)). 
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Fig. 6. Anterior cruciate ligament reconstruction procedure in the sheep model.  A: 
semitendinosus tendon graft, B: a radiographic lateral view immediately after the surgery 
(From ref. Kondo (2011)). 
 
 
Fig. 7. The effects of VEGF application on A-P displacement between ±100-N A-P forces 
(From ref. Yoshikawa (2006b)) . Group I: the knee 12 weeks after ACL reconstruction with 
semitendinosus tendon graft soaked in phosphate buffered saline, Group II: the knee 12 
weeks after ACL reconstruction with semitendinosus tendon graft soaked in VEGF solution, 
Normal: normal knee with no treatment. 
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Fig. 8. The effects of VEGF application on structural properies of the femur-graft-tibia 
complex after ACL reconstruction (A: The linear stiffness; B: The ultimate failure load; C: 
The absorbed energy; D: Elongation at failure) (From ref. Yoshikawa (2006b)). Group I: the 
femur-graft-tibia complex 12 weeks after ACL reconstruction with semitendinosus tendon 
graft soaked in phosphate buffered saline, Group II: the femur-graft-tibia complex 12 weeks 
after ACL reconstruction with semitendinosus tendon graft soaked in VEGF solution, 
Normal: normal the femur-graft-tibia complex with no treatment. 
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We did not know exactly why our VEGF application reduced the stiffness of the grafted 
tendon after ACL reconstruction. Shrive et al. (1995) reported that in the medial collateral 
ligament injury model in the rabbit, the area of newly formed vessels, infiltrative cells and 
disorderly arranged collagen fibers in the scar tissue was reversely correlated with mechanical 
strength of the scar tissue and that a number of newly formed vessels and infiltrative cells 
might act as “flaws” and enhance the deterioration of the mechanical property of the grafted 
tendon. Therefore, a number of newly formed vessels and infiltrative cells which VEGF 
administration induced in the ACL graft might deteriorate mechanical properties of the ACL 
graft as soft tissue flaws. In addition, it was reported that VEGF promotes collagenese 
production by some types of cells (Ferrara, 1997; Munaut, 2003; Pufe, 2004; Zachary, 1998). 
Therefore, VEGF-induced collagenese directly might digest the matrix of the graft. VEGF was 
widely used for patients with extensive tissue ischemia in whom primary vascular 
reconstruction procedures were not feasible or had previously failed in clinical trials 
(Kusumanto, 2003).  Early clinical data provide evidence that the VEGF application can 
achieve beneficial angiogenesis, with minimal side-effects.  Our findings imply that an 
application of the recombinant VEGF therapy can supposedly enhance revascularization in the 
graft as well as cellular infiltration after ACL reconstruction. On the other hand, our 
biomechanical results have indicated that exogenous VEGF application decreases the stiffness 
of the grafted tendon at least temporarily after ACL reconstruction. Therefore, if we intend to 
apply exogenous VEGF as a treatment to accelerate angiogenesis and cellular infiltration in the 
tendon graft for ACL reconstruction, we should take into account this adverse effect of 
exogenous VEGF application on the mechanical characteristics of the grafted tendon. 
3.2 Growth factor application for collagen synthesis in fibroblasts  
Numerous studies have shown that various types of cells can over-expressed growth factors 
such as transforming growth factor-beta (TGF-beta), basic fibroblast growth factor (b-FGF), 
and platelet-derived growth factor (PDGF), epidermal growth factor (EGF) during healing 
process of the tissue. In addition, these factors regulate the synthesis and degradation of 
collagen by the fibroblasts of tendons and ligaments. Therefore, the effects of growth factors 
on mRNA expression of MMP-13, which is main collagenase in the rat, were evaluated in 
the rat model using Northern blot analysis. At 6 hours after the challenge with PDGF-BB, 
up-regulation of MMP-13 mRNA became apparent at the dose of 100 ng/ml, while slight 
up-regulation of MMP-13 mRNA was observed at the dose of 10 ng/ml (Fig. 9A). In 
contrast, down-regulation of MMP-13 mRNA was found at 6 hours after the stimulation 
with TGF-beta1. The suppression of MMP-13 mRNA by TGF-beta1 was dose-dependent in 
the range less than 10 ng/ml (Fig. 9A). We also found that TGF-beta1 significantly increases 
the ratio of type I collagen mRNA to type III collagen mRNA in extrinsic fibroblasts 
infiltrative fibroblasts (Fig. 9-B). It is well known that EGF stimulates fibroblast proliferation 
in vitro (Schmidt, 1995). A combined application of these two growth factors enhances these 
effects (DesRosiers, 1996). Therefore, we conducted following animal experimental studies 
for the application of TGF-beta1 and EGF to ligament reconstruction.  
First, we investigated the effects of a combined application of TGF-beta and EGF on the 
rabbit in situ frozen-thawed ACL (Sakai, 2002). In this study, a low and a high doses of 
combinations (low dose: 4-ng TGF-beta1 and 100-ng EGF, high dose: 2-microgram TGF-
beta1 and 50-microgram EGF) mixed with the fibrin sealant were applied to rabbit ACLs 
after the in situ freeze-thaw treatment, compared with in situ frozen-thawed ACLs without 
any other treatment and with fibrin sealant alone. These ACLs were evaluated at 12 weeks 
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Fig. 9. The effects of growth factors on gene expression of extrinsic infiltrating fibroblasts 
into the patellar tendon after the necrosis (A. MMP-13 mRNA; B. type-I and type-II 
collagens mRNAs). 
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Fig. 10. Histograms of the collagen fibril diameter in the normal control ACL (A) and the 
ACL after the in situ freeze-thaw treatment without TGF-beta/EGF application (B) and with 
a high dose of TGF-beta and EGF ((From ref. Sakai (2002)). 
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Fig. 11. The effects of low-dose application of TGF-beta and EGF on structural properties of 
the femur-graft-tibia complex after ACL reconstruction (From ref. Yasuda (2004)). A. ACL 
reconstruction procedure with the bone–patellar tendon–bone graft, B. The load-elongation 
curves of the femur-graft-tibia complexes in the knees with growth factor application (GF), 
with fibrin sealant alone (Sham), and without growth factor or fibrin sealant (Control) 
groups and the normal femur-ACL-tibia complex (Normal ACL). 
www.intechopen.com
  
Biomechanics in Applications 
 
96
 
Fig. 12. The effects of a separate application of TGF-beta, EGF, and PDGF-BB on the material 
properties of the ACL 12 weeks after the in situ freeze-thaw treatment (From ref. Nagumo 
(2005)). The stress–strain curves of the anteromedial bundle of the ACL in Group I (G-I, only 
0.2 ml fibrin sealant was applied), Group II (G-II, 4 ng TGF-beta1 mixed with 0.2 ml fibrin 
sealant was applied), Groups III (G-III, 100 ng EGF mixed 0.2 ml fibrin sealant was applied) 
Group IV (G-IV, 4 μg PDGF-BB mixed with 0.2 ml fibrin sealant was applied) and Group 
“contralateral control” (G-CC). 
on the basis of mechanical properties, water content, and histological and ultrastructural 
observations. As a result, the cross-sectional area and the water content of ACLs with a low 
dose of TGF-beta1 and EGF were significantly less than those of ACLs with other treatments 
at 12 weeks. The tensile strength of ACLs with a low dose of TGF-beta1 and EGF was 
significantly greater than those of ACLs with other treatments at 12 weeks. In addition, the 
average tangent modulus of with a low dose of TGF-beta and EGF was 96% of the average 
value in the normal ACLs, while that with a low dose of TGF-beta and EGF was 68% of the 
normal ACLS. A unimodal distribution of collagen fibril diameters was noted in ACLs 
without TGF-beta/EGF application, while a bimodal pattern was found in ACLs with a low 
dose of TGF-beta1 and EGF (Fig. 10). These findings revealed that low-dose application of 
TGF-beta and EGF significantly inhibited not only the increased water content and cross-
sectional area, but also the decreased tensile strength caused by the freeze-thaw treatment, 
while a high dose of TGF-beta and EGF does not have the same beneficial effects. 
Second, we conducted a canine model study to clarify if low-dose application of TGF-beta 
and EGF enhances the mechanical properties of the grafted tendon after ACL reconstruction 
(Yasuda, 2004).  In this study, 20 dogs underwent ACL reconstruction with the autogenous 
bone-patellar tendon-bone graft, which is a standard graft for ACL reconstruction, in 
bilateral knees. A combination of 12 ng TGF -beta and 300 ng EGF mixed with fibrin sealant 
was applied to the left knee and compared to the right knee without any treatment after 
identical ACL reconstruction procedure to the left side. In the remaining 10 dogs, fibrin 
sealant alone was applied to the left knee. We then found that combined application of TGF-
beta and EGF increased the stiffness and maximum failure load of the femur-graft-tibia 
complex at 12 weeks, while the application of fibrin sealant alone did not significantly affect 
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them (Fig.11). Our findings suggest that application of transforming growth factor-beta and 
epidermal growth factor improves the structural properties of the femur-graft-graft complex 
after ACL reconstruction. Therefore, application of growth factors is a possible strategy to 
prevent graft deterioration in ACL reconstruction. 
Third, we evaluated effects of a separate application of TGF-beta, EGF, and PDGF-BB on the 
material properties of the in situ frozen-thawed ACL (Nagumo, 2005). In this study, we 
applied 4 ng TGF-beta, 20 ng EGF, and 4 microgram PDGF-BB to the ACL after the in situ 
freeze-thaw treatment, separately. We also applied only fibrin sealant to the ACL after the in 
situ freeze-thaw treatment as a control. At 12 weeks after growth factor application, the tensile 
strength and the tangent modulus of the ACL with TGF-beta application was significantly 
higher than in the control group (Fig. 12). On the other hand, there were no significant 
differences in the strength and the modulus among the ACLs with EGF application, PDGF-BB 
application and the controls. These findings suggests that that the effect of TGF-beta was 
significant, but the effect of EGF not. Therefore, there is the possibility that the application of 
TGF-beta enhances maturation of the graft after ligament reconstruction. 
4. Conclusion 
After ligament reconstruction, the cell infiltration into a core portion of the graft is 
considered to occur very slowly (Delay, 2002). The slow graft maturation may result in graft 
failure during the postoperative rehabilitation period. In this chapter, the authors showed 
the recent experimental findings suggesting that an administration of growth factors, in 
particular, TGF-beta can inhibit the deterioration of mechanical properties of the grafted 
tendon after ACL reconstruction.  Therefore, application of growth factors, in particular 
TGF-beta, is a possible strategy to enhance maturation of the graft after ligament 
reconstruction. However, a few recent studies reported that TGF-beta induced arthritic 
changes of the articular cartilage in the knee joint (Hulth, 1996; van Beuningen, 1994).  
Therefore, intraarticular administration of TGF-beta may be unsuitable for clinical 
application with an ACL reconstruction procedure. The cell-based therapy with cellular 
activation by growth factors may be a potential solution against this problem (Kondo, 2011; 
Okuizumi, 2004). The recent advancement in biology about ligament reconstruction can 
bring new strategies in additional therapeutic options to accelerate the remodeling of the 
graft and enhance mechanical strength of the grafted tendon after ACL reconstruction. 
5. Acknowledgment 
The authors acknowledge Yasunari Ikema, M.D., Ph.D., Young-Jin Ju M.D., Ph.D., 
Toshikazu Yoshikawa M.D., Ph.D., Fumihisa Tomita, M.D., Ph.D., and Akira Nagumo, 
M.D., Ph.D. for their contribution as primary investigators of the studies which were 
introduced in this chapter.  
6. References 
Amiel, D., Kleiner, J.B., & Akeson, W.H. (1986). The natural history of the anterior cruciate 
ligament autograft of patellar tendon origin. Am J Sports Med, 14, pp.449-462 
Amiel, D., Nagineni, C.N., Choi, S.H., & Lee, D. (1995). Intrinsic properties of ACL and MCL 
cells and their responses to growth factors. Med Sci Sports Exerc, 27, pp. 844-851 
www.intechopen.com
  
Biomechanics in Applications 
 
98
Arnoczky, S.P., Tarvin, G.B., & Marshall, J.L. (1982). Anterior cruciate ligament replacement 
using patellar tendons. J Bone and Joint Surg Am, 64, pp.217-24 
Beynnon, B.D., Risberg, M.A., Tjormsland, O., Ekeland, A., Fleming, B.C., Peura, G.D., & 
Johnson, R.J. (1997). Evaluation of knee joint laxity and the strucural properties of 
the anterior cruciate ligament graft in the human. A case report. Am J Sports Med, 
25: pp.203-206 
Boden, B., Dean, G., Feagin, J. Jr., & Garrett, W. Jr. (2000). Mechanisms of anterior cruciate 
ligament injury. Orthopedics, 2000, 23(6), pp.573-578. 
Deie, M., Marui, T., Allen, C.R., Hildebrand, K.A., Georgescu, H.I., Niyibizi, C., & Woo, S.L. 
(1997). The effects of age on rabbit MCL fibroblast matrix synthesis in response to 
TGF-beta 1 or EGF. Mech Ageing Dev, 97, pp. 121-130 
Delay, B.S., McGrath, B.E., & Mindell, E.R. (2002). Observations on a retrieved patellar 
tendon autograft used to reconstruct the anterior cruciate ligament. A case report. J 
Bone Joint Surg Am, 84-A, pp.1433-438 
DesRosiers, E.A., Yahia, L., & Rivard, C.H. (1996). Proliferative and matrix synthesis 
response of canine anterior cruciate ligament fibroblasts submitted to combined 
growth factors. J Orthop Res, 14, pp.200-208 
Ferrara, N., & Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. 
Endocr Rev, 18, pp.4-25 
Hannafin, J.A., Attia, E.T., Warren, R.F., & Bhargava, M.M. (1999). Characterization of 
chemotactic migration and growth kinetics of canine knee ligament fibroblasts. J 
Orthop Res, 17, pp. 398-404. 
Hulth, A., Johnell, O., Miyazono, K., Lindberg, L., Heinegard, D., & Heldin, C.H. (1996). 
Effect of transforming growth factor-beta and platelet-derived growth factor-BB on 
articular cartilage in rats. J Orthop Res, 14, pp.547-553 
Ikema, Y., Tohyama, H., Nakamura, H., Kanaya, F., & Yasuda, K. (2005). Growth kinetics 
and integrin expression of fibroblasts infiltrating devitalised patellar tendons are 
different from those of intrinsic fibroblasts. J Bone Joint Surg Br, 87(12), pp. 1689-
1693. 
Jackson, D.W., Grood, E.S., Cohn, B.T., Arnoczky, S.P., Simon, T.M., & Cummings, J.F. (1991)  
The effects of in situ freezing on the anterior cruciate ligament. An experimental 
study in goats. J Bone Joint Surg Am, 73, pp.201-213 
Ju, Y.J., Tohyama, H., Kondo, E., Yoshikawa, T., Muneta, T., Shinomiya, K., & Yasuda, K. 
(2006). Effects of local administration of vascular endothelial growth factor on 
properties of the in situ frozen-thawed anterior cruciate ligament in rabbits. Am J 
Sports Med, 34(1), pp.84-91 
Katsuragi, R., Yasuda, K., Tsujino, J., Keira, M., & Kaneda, K. (2000) The effect of 
nonphysiologically high initial tension on the mechanical properties of in situ 
frozen anterior cruciate ligament in a canine model. Am J Sports Med, 28, pp.47–56 
Kleiner, J.B., Amiel, D., Roux, R.D., & Akeson, W.,H. (1986). Origin of replacement cells for 
the anterior cruciate ligament autograft. J Orthop Res, 4, pp.466-474  
Kobayashi K, Healey RM, Sah, R.L., Clark, J.J., Tu, B.P., Goomer, R.S., Akeson, W.H., 
Moriya, H., & Amiel, D. (2000). Novel method for the quantitative assessment of 
cell migration: a study on the motility of rabbit anterior cruciate (ACL) and medial 
collateral ligament (MCL) cells. Tissue Eng, 6, pp.29-38 
www.intechopen.com
Application of Growth Factors for Enhancement of  
Mechanical Strength of Grafted Tendon Following Anterior Cruciate Ligament Reconstruction 
 
99 
Kondo, E., Yasuda, K., Katsura, T., Hayashi, R., Azuma, C., & Tohyama H. (2011) Local 
Administration of Autologous Synovium-Derived Cells Improve the Structural 
Properties of Anterior Cruciate Ligament Autograft Reconstruction in Sheep. Am J 
Sports Med, 39(5), pp.999-1007. 
Kusumanto, Y.H., Hospers, G.A., Mulder, N.H., & Tio, R.A. (2003). Therapeutic 
angiogenesis with vascular endothelial growth factor in peripheral and coronary 
artery disease: a review. Int J Cardiovasc Intervent, 5, pp.27-34 
Marui, T., Niyibizi, C., Georgescu, H.I., Cao, M., Kavalkovich, K.W., Levine, R.E., & Woo, 
S.L. (1997). Effect of growth factors on matrix synthesis by ligament fibroblasts. J 
Orthop Res, 15, pp.18-23 
Munaut, C., Noel, A., Hougrand, O., Foidart, J.M., Boniver, J., & Deprez, M. (2003). Vascular 
endothelial growth factor expression correlates with matrix metalloproteinases 
MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer, 106, pp.848-
855 
Nagumo, A., Yasuda, K., Numazaki, H., Azuma, H., Tanabe, Y., Kikuchi, S., Harata, S., & 
Tohyama, H. (2005). Effects of separate application of three growth factors (TGF-
beta1, EGF, and PDGF-BB) on mechanical properties of the in situ frozen-thawed 
anterior cruciate ligament. Clin Biomech (Bristol, Avon), 20(3), pp.283-290. 
Okuizumi, T., Tohyama, H., Kondo, E., & Yasuda, K. (2004). The effect of cell-based therapy 
with autologous synovial fibroblasts activated by exogenous TGF-beta1 on the in 
situ frozen-thawed anterior cruciate ligament. J Orthop Sci, 9(5), pp.488-494 
Pufe, T., Harde, V., Petersen, W., Goldring, M.B., Tillmann, B., & Mentlein, R. (2004). 
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase 
expression in immortalized chondrocytes. J Pathol, 202, pp.367-374 
Sakai, T., Yasuda, K., Tohyama, H., Azuma, H., Nagumo, A., Majima, T., & Frank, C.B. 
(2002). Effects of combined administration of transforming growth factor-beta1 and 
epidermal growth factor on properties of the in situ frozen anterior cruciate 
ligament in rabbits. J Orthop Res, 20(6), pp.1345-1351 
Scherping, S.C. Jr., Schmidt, C.C., Georgescu, H.I., Kwoh, C.K., Evans, C.H., & Woo, S.L. 
(1997). Effect of growth factors on the proliferation of ligament fibroblasts from 
skeletally mature rabbits. Connect Tissue Res, 36, pp.1-8 
Schmidt, C.C., Georgescu, H.I., Kwoh, C.K., Blomstrom, G.L., Engle, C.P., Larkin, L.A., 
Evans, C.H., & Woo, S.L. (1995). Effect of growth factors on the proliferation of 
fibroblasts from the medial collateral and anterior cruciate ligaments. J Orthop Res, 
13, pp.184-190 
Shrive, N., Chimich, D., Marchuk, L., Wilson, J., Brant, R., & Frank, C. (1995). Soft-tissue 
“flaws” are associated with the material properties of the healing rabbit medial 
collateral ligament. J Orthop Res, 13, pp.923-929 
Tohyama, H., & Yasuda, K. (2000). Extrinsic cell infiltration and revascularization accelerate 
mechanical deterioration of the patellar tendon after fibroblast necrosis. J Biomech 
Eng, 122(6), pp.594-599 
Tohyama, H., Yasuda, K., & Uchida, H. (2006). Is the increase in type III collagen of the 
patellar tendon graft after ligament reconstruction really caused by 
"ligamentization" of the graft? Knee Surg Sports Traumatol Arthrosc, 14(12), 
pp.1270-1277. 
www.intechopen.com
  
Biomechanics in Applications 
 
100 
Tohyama, H., Yasuda, K., Uchida, H., & Nishihira, J. (2007). The responses of extrinsic 
fibroblasts infiltrating the devitalised patellar tendon to IL-1beta are different from 
those of normal tendon fibroblasts. J Bone Joint Surg Br, 89(9), pp.1261-1267 
Uhorchak, M., Scoville, R., Williams, G., Arciero, R., St Pierre, P., & Taylor, D. (2003). Risk 
factors associated with noncontact injury of the anterior cruciate ligament: A 
prospective four-year evaluation of 859 West Point cadets. Am J Sports Med, 31(6), 
pp. 831-842 
van Beuningen, H.M., van der Kraan, P.M., Arntz, O.J., & van den Berg, W.B. (1994). 
Transforming growth factor-beta 1 stimulates chondrocyte proteoglycan synthesis 
and induces osteophyte formation in the murine knee joint. Lab Invest, 71, pp.279-
290 
Yasuda,K., Tomita, F., Yamazaki, S., Minami, A., Tohyama, H. (2004). The effect of growth 
factors on biomechanical properties of the bone-patellar tendon-bone graft after 
anterior cruciate ligament reconstruction: a canine model study. Am J Sports Med, 
32(4), pp.870-880 
Yoshikawa, T., Tohyama, H., Enomoto, H., Matsumoto, H., Toyama, Y., & Yasuda, K. 
(2006a) Expression of vascular endothelial growth factor and angiogenesis in 
patellar tendon grafts in the early phase after anterior cruciate ligament 
reconstruction. Knee Surg Sports Traumatol Arthrosc, 14(9), pp.804-810 
Yoshikawa, T., Tohyama, H., Katsura, T., Kondo, E., Kotani, Y., Matsumoto, H., Toyama, Y., 
& Yasuda, K. (2006b). Effects of local administration of vascular endothelial growth 
factor on mechanical characteristics of the semitendinosus tendon graft after 
anterior cruciate ligament reconstruction in sheep. Am J Sports Med, 34(12), 
pp.1918-1925 
Zachary, I. (1998). Vascular endothelial growth factor. Int J Biochem Cell Biol, 30, pp.1169-
1174 
www.intechopen.com
Biomechanics in Applications
Edited by Dr Vaclav Klika
ISBN 978-953-307-969-1
Hard cover, 408 pages
Publisher InTech
Published online 09, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
During last couple of years there has been an increasing recognition that problems arising in biology or related
to medicine really need a multidisciplinary approach. For this reason some special branches of both applied
theoretical physics and mathematics have recently emerged such as biomechanics, mechanobiology,
mathematical biology, biothermodynamics. The Biomechanics in Application is focusing on experimental praxis
and clinical findings. The first section is devoted to Injury and clinical biomechanics including overview of the
biomechanics of musculoskeletal injury, distraction osteogenesis in mandible, or consequences of drilling. The
next section is on Spine biomechanics with biomechanical models for upper limb after spinal cord injury and an
animal model looking at changes occurring as a consequence of spinal cord injury. Section Musculoskeletal
Biomechanics includes the chapter which is devoted to dynamical stability of lumbo-pelvi-femoral complex
which involves analysis of relationship among appropriate anatomical structures in this region. The fourth
section is on Human and Animal Biomechanics with contributions from foot biomechanics and chewing
rhythms in mammals, or adaptations of bats. The last section, Sport Biomechanics, is discussing various
measurement techniques for assessment and analysis of movement and two applications in swimming.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Harukazu Tohyama and Kazunori Yasuda (2011). Application of Growth Factors for Enhancement of
Mechanical Strength of Grafted Tendon Following Anterior Cruciate Ligament Reconstruction, Biomechanics in
Applications, Dr Vaclav Klika (Ed.), ISBN: 978-953-307-969-1, InTech, Available from:
http://www.intechopen.com/books/biomechanics-in-applications/application-of-growth-factors-for-
enhancement-of-mechanical-strength-of-grafted-tendon-following-ant
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
